What is the status of biosimilars suffix use in LATAM for pharmaco vigilance purposes ?

What are the label requirements in LATAM cocerning the biosimilars suffix, to differentiate them from the reference biologic? In what countries is enforced to use the suffix for pharmacovigilance...

30 December 2018 5,839 1 View